451 related articles for article (PubMed ID: 15191787)
1. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by iscoms, immune stimulating complexes.
Morein B; Bengtsson KL
Methods; 1999 Sep; 19(1):94-102. PubMed ID: 10525444
[TBL] [Abstract][Full Text] [Related]
3. Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes.
Claassen IJ; Osterhaus AD; Claassen E
Eur J Immunol; 1995 May; 25(5):1446-52. PubMed ID: 7774649
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
Koopman G; Bogers WM; van Gils M; Koornstra W; Barnett S; Morein B; Lehner T; Heeney JL
J Med Virol; 2007 May; 79(5):474-82. PubMed ID: 17385685
[TBL] [Abstract][Full Text] [Related]
5. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
[TBL] [Abstract][Full Text] [Related]
6. Iscom, a delivery system for parenteral and mucosal vaccination.
Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
[TBL] [Abstract][Full Text] [Related]
7. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
8. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
9. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
[TBL] [Abstract][Full Text] [Related]
11. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
Paillot R; Prowse L
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
[TBL] [Abstract][Full Text] [Related]
12. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses.
Smith RE; Donachie AM; Grdic D; Lycke N; Mowat AM
J Immunol; 1999 May; 162(9):5536-46. PubMed ID: 10228035
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulating complexes (ISCOMs) for nasal vaccination.
Hu KF; Lövgren-Bengtsson K; Morein B
Adv Drug Deliv Rev; 2001 Sep; 51(1-3):149-59. PubMed ID: 11516786
[TBL] [Abstract][Full Text] [Related]
14. A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.
Eliasson DG; Helgeby A; Schön K; Nygren C; El-Bakkouri K; Fiers W; Saelens X; Lövgren KB; Nyström I; Lycke NY
Vaccine; 2011 May; 29(23):3951-61. PubMed ID: 21481325
[TBL] [Abstract][Full Text] [Related]
15. Global transcriptional response to ISCOM-Matrix adjuvant at the site of administration and in the draining lymph node early after intramuscular injection in pigs.
Ahlberg V; Lövgren Bengtsson K; Wallgren P; Fossum C
Dev Comp Immunol; 2012 Sep; 38(1):17-26. PubMed ID: 22426325
[TBL] [Abstract][Full Text] [Related]
16. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
Estrada A; Laarveld B; Li B; Redmond MJ
Immunol Invest; 1995 Aug; 24(5):819-28. PubMed ID: 8543345
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory complexes containing Eimeria tenella antigens and low toxicity plant saponins induce antibody response and provide protection from challenge in broiler chickens.
Berezin VE; Bogoyavlenskyi AP; Khudiakova SS; Alexuk PG; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Barfield RC; Fetterer RH
Vet Parasitol; 2010 Jan; 167(1):28-35. PubMed ID: 19879050
[TBL] [Abstract][Full Text] [Related]
18. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
19. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine.
Aguila A; Donachie AM; Peyre M; McSharry CP; Sesardic D; Mowat AM
Vaccine; 2006 Jun; 24(24):5201-10. PubMed ID: 16650917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
